http://www.inc.com/magazine/201402/david-freedman/obamacare-healt...

http://www.inc.com/magazine/201402/david-freedman/obamacare-health-technology-startups.html

Isonea offer a product for chronic management of Asthma which is already known 2/3's of patients have no monitoring or management of their Asthma, incentives which lowers health costs will be pushed to these non management types who clog up the health care system (clinics,ambo's,Hospitals.)

Those who do monitor will have the additional features current management plans dont offer. Health Fund rebates if shown to be actively monitoring another feature yet to come. Higher premiums for the non compilers who get the ambo ride to hospital for a condition that could have been avoided by active monitoring..

There is a huge market once they get the sales ball rolling. Private equity may even have a sniff if the price gets lower or may take a piece of the pie under a capital injection when ISN's cash gets lower over the coming quarters.